Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Journal of Rural Mental Health ; : No Pagination Specified, 2023.
Article in English | APA PsycInfo | ID: covidwho-2275233

ABSTRACT

Many consumers, both youth and adults, are not accessing appropriate substance use treatment, necessitating the need for mobile response interventions. Choices Coordinated Care Solutions has developed a mobile response model that builds on Systems of Care values to engage consumers in intensive care coordination utilizing the evidence-based Screening, Brief Intervention, and Referral to Treatment approach and core values of wraparound. The choices emergency response team (CERT) model is an integrated, coordinated service delivery approach, relying on the skills and experience of its qualified staff to work with consumers in order to effectively identify the inherent strengths that all people have and to use those strengths to design innovative, trauma-informed approaches to treatment. A strong relationship with a broad network of stakeholders throughout the state and southeast Indiana serves as a foundation for the implementation of mobile response. These relationships with local resources empower consumers in their recovery journey. The evolution of the CERT model to strategically integrate technology, especially with incarcerated or justice-involved consumers, became an essential asset during the COVID-19 epidemic in 2020. The necessity of virtual consumer engagement has created opportunities for these recovery communities that may endure even after the pandemic is resolved. (PsycInfo Database Record (c) 2023 APA, all rights reserved) Impact Statement Crises related to substance use create significant burdens on individuals, families, and communities. Mobile response facilitates access to substance use treatments. This article describes key components of an emergency response model and how technology played an essential role in engaging consumers during the pandemic. (PsycInfo Database Record (c) 2023 APA, all rights reserved)

2.
Int J Emerg Med ; 16(1): 9, 2023 Feb 20.
Article in English | MEDLINE | ID: covidwho-2263410

ABSTRACT

BACKGROUND: During the coronavirus disease 2019 (COVID-19) pandemic, the format of patients with out-of-hospital cardiac arrest (OHCA) management was modified. Therefore, this study compared the response time and survival at the scene of patients with OHCA managed by emergency medical services (EMS) before and during the COVID-19 pandemic in Thailand. METHODS: This retrospective, observational study used EMS patient care reports to collect data on adult patients with OHCA coded with cardiac arrest. Before and during the COVID-19 pandemic was defined as the periods of January 1, 2018-December 31, 2019, and January 1, 2020-December 31, 2021, respectively. RESULTS: A total of 513 and 482 patients were treated for OHCA before and during the COVID-19 pandemic, respectively, showing a decrease of 6% (% change difference =- 6.0, 95% confidence interval [CI] - 4.1, - 8.5). However, the average number of patients treated per week did not differ (4.83 ± 2.49 vs. 4.65 ± 2.06; p value = 0.700). While the mean response times did not significantly differ (11.87 ± 6.31 vs. 12.21 ± 6.50 min; p value = 0.400), the mean on-scene and hospital arrival times were significantly higher during the COVID-19 pandemic compared with before by 6.32 min (95% CI 4.36-8.27; p value < 0.001), and 6.88 min (95% CI 4.55-9.22; p value < 0.001), respectively. Multivariable analysis revealed that patients with OHCA had a 2.27 times higher rate of return of spontaneous circulation (ROSC) (adjusted odds ratio = 2.27, 95% CI 1.50-3.42, p value < 0.001), and a 0.84 times lower mortality rate (adjusted odds ratio = 0.84, 95% CI: 0.58-1.22, p value = 0.362) during the COVID-19 pandemic period compared with that before the pandemic. CONCLUSIONS: In the present study, there was no significant difference between the response time of patients with OHCA managed by EMS before and during COVID-19 pandemic period; however, markedly longer on-scene and hospital arrival times and higher ROSC rates were observed during the COVID-19 pandemic than those in the period before the pandemic.

3.
Crop Science ; 2022.
Article in English | Web of Science | ID: covidwho-2103515

ABSTRACT

Ginger (Zingiber officinale Roscoe) is a rhizomatous plant with wide usage in the food, pharmaceutical, and cosmetic industries. The inclusion of ginger rhizomes in the home remedies for prophylaxis related to COVID-19 infection may have caused a sharp rise in global ginger demand that has exceeded supply. To meet this demand, there is a need to identify high yielding genotypes with desirable attributes. The objectives of this study were to characterize and identify morphological markers that are associated with high rhizome yields. Ten ginger genotypes were assessed for 2 yr for their yield and phytochemical and mineral compositions under a randomized complete block design with three replications. A hierarchical cluster analysis was performed on the genotypes based on eight morphological attributes and 15 phytoconstituent contents. The results showed three clusters and two outliers. The dendrogram identified cluster A with genotypes KD-2 and EN-1 as the highest rhizome yielder. The pseudo-stem diameter (.808), leaf width (.743), plant height (.722), and the number of leaves plant(-1) (.641) showed the highest correlation coefficients with the ginger rhizome yield. The path coefficient analysis showed that 70.6% of the contribution of the pseudo-stem diameter to the rhizome yield occurred through its indirect effect on the leaf width (47.2%) and plant height (23.4%). These markers should be considered in selecting high-yielding ginger genotypes for production.

4.
R I Med J (2013) ; 105(7): 58-61, 2022 Sep 01.
Article in English | MEDLINE | ID: covidwho-2012170

ABSTRACT

Throughout the COVID-19 pandemic, there has been growing but limited data describing the poor mortality outcomes in COVID-19 patients who experienced In-Hospital Cardiac Arrest (IHCA). This study evaluated the baseline characteristics and outcomes of COVID-19 patients who underwent cardiopulmonary resuscitation (CPR) during hospitalization in the early phases of the pandemic and compared them to that of several national and international centers. A list of all the IHCA events in the Lifespan hospital network from March 2020 to April 2021 was generated, and data, including de-identified patient characteristics, comorbidities, and details of the IHCA event, were examined. The primary outcome of all-cause mortality was then calculated. Forty-three patients with COVID-19 who experienced an IHCA event and underwent CPR were identified. Return of spontaneous circulation (ROSC) was achieved in 23 (53%) patients, and all-cause in-hospital mortality was 97.67%, with only one patient surviving until discharge. During the early pandemic, experiencing an IHCA event while admitted with COVID-19 carried an extremely poor prognosis, even if ROSC was achieved. This outcome likely reflects the lack of clear management guidelines or established therapeutic agents and the prevalence of the Delta strain during this time period.


Subject(s)
COVID-19 , Cardiopulmonary Resuscitation , Heart Arrest , Heart Arrest/etiology , Heart Arrest/therapy , Hospitals , Humans , Pandemics
5.
Am J Emerg Med ; 51: 64-68, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-1458554

ABSTRACT

OBJECTIVE: A decline in OHCA performance metrics during the pandemic has been reported in the literature but the cause is still not known. The Montgomery County Fire and Rescue Service (MCFRS) observed a decline in both the rate of return of spontaneous circulation (ROSC) and the proportion of resuscitations that resulted in cerebral performance category (CPC) 1 or 2 discharge of the patient beginning in March of 2020. This study examines whether the decline in these performance metrics persists when known COVID positive patients are excluded from the analysis. METHODS: Two samples of OHCA patients for similar time periods (one year apart) before and after the start of the COVID pandemic were developed. A database of known COVID positive patients among EMS encounters was used to identify and exclude COVID positive patients. OHCA outcomes in these two groups were then compared using a Chi-square test and Fisher's exact test for difference in proportions and Analysis of Variance (ANOVA) for difference in means. A two-stage multivariable logistic regression model was used to develop odds ratios for achieving ROSC and CPC 1 or 2 discharge in each period. RESULTS: After excluding known COVID patients, 32.5% of the patients in the pre-COVID period achieved ROSC compared to 25.1% in the COVID period (p = 0.007). 6% of patients in the pre-COVID period were discharged with CPC 1 or 2 compared to 3.2% from the COVID era (p = 0.026). Controlling for all available patient characteristics, patients undergoing OHCA resuscitation prior to be beginning of the pandemic were 1.2 times more likely to achieve ROSC and 1.6 times more likely to be discharged with CPC 1 or 2 than non-COVID patients in the pandemic era sample. CONCLUSIONS: When known COVID patients are excluded, pre-pandemic OHCA resuscitation patients were more likely to achieve ROSC and CPC 1 or 2 discharge. The prevalence of known COVID positive patients among all OHCA resuscitations during the pandemic was not sufficient to fully account for the marked decrease in both ROSC and CPC 1 or 2 discharges. Other causative factors must be sought.


Subject(s)
Benchmarking , Emergency Medical Services/statistics & numerical data , Out-of-Hospital Cardiac Arrest/epidemiology , Patient Discharge/statistics & numerical data , Aged , Aged, 80 and over , Analysis of Variance , COVID-19 , Chi-Square Distribution , Female , Humans , Logistic Models , Male , Maryland , Middle Aged , Odds Ratio , Pandemics , Resuscitation , Retrospective Studies , Return of Spontaneous Circulation
6.
Open Access Emerg Med ; 13: 431-438, 2021.
Article in English | MEDLINE | ID: covidwho-1443912

ABSTRACT

PURPOSE: The quality of resuscitation for out hospital cardiac arrest (OHCA) during the COVID-19 era could be affected. We aim to describe prehospital healthcare providers' resuscitative efforts for OHCA cases and their definitive outcomes. PATIENTS AND METHODS: This retrospective cross-sectional study included all OHCA cases between April and June 2021 across all regions in the Kingdom of Saudi Arabia (KSA). Demographic variables, response times, CPR providers, initial rhythm, use of AED/Defibrillator, medical interventions, ROSC data, and dispatch codes were extracted from a central electronic platform. RESULTS: A total of 1307 OHCA cases were included in this study, males constituted 65% and 42% were ≥65 years. Although the median response time to initiate CPR was 13 min, 11% of OHCA cases had a response time between 0 and 6 min. About 75% of CPR was provided on scene by BLS units, 78% of OHCA cases had asystole as their initial rhythm, an AED/Defibrillator was used more than 90% of the time for pulseless VT/VF rhythm, and ROSC was achieved in 8% of OHCA patients. CONCLUSION: During the COVID-19 pandemic, maintaining resuscitative efforts for OHCA continues in KSA. Closing knowledge gaps in the community and a better description of OHCA for the dispatcher could guide dispatch-assisted CPR and minimize OHCA response times.

7.
Resusc Plus ; 4: 100054, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-939226

ABSTRACT

AIMS: To define outcomes of patients with COVID-19 compared to patients without COVID-19 suffering in-hospital cardiac arrest (IHCA). MATERIALS AND METHODS: We performed a single-center retrospective study of IHCA cases. Patients with COVID-19 were compared to consecutive patients without COVID-19 from the prior year. Return of spontaneous circulation (ROSC), 30-day survival, and cerebral performance category (CPC) at 30-days were assessed. RESULTS: Fifty-five patients with COVID-19 suffering IHCA were identified and compared to 55 consecutive IHCA patients in 2019. The COVID-19 cohort was more likely to require vasoactive agents (67.3% v 32.7%, p = 0.001), invasive mechanical ventilation (76.4% v 23.6%, p < 0.001), renal replacement therapy (18.2% v 3.6%, p = 0.029) and intensive care unit care (83.6% v 50.9%, p = 0.001) prior to IHCA. Patients with COVID-19 had shorter CPR duration (10 min v 22 min, p = 0.002). ROSC (38.2% v 49.1%, p = 0.336) and 30-day survival (20% v 32.7%, p = 0.194) did not differ. A 30-day cerebral performance category of 1 or 2 was more common among non-COVID patients (27.3% v 9.1%, p = 0.048). CONCLUSIONS: Return of spontaneous circulation and 30-day survival were similar between IHCA patients with and without COVID-19. Compared to previously published data, we report greater ROSC and 30-day survival after IHCA in COVID-19.

8.
Resuscitation ; 151: 18-23, 2020 06.
Article in English | MEDLINE | ID: covidwho-46293

ABSTRACT

OBJECTIVE: To describe the characteristics and outcomes of patients with severe COVID-19 and in-hospital cardiac arrest (IHCA) in Wuhan, China. METHODS: The outcomes of patients with severe COVID-19 pneumonia after IHCA over a 40-day period were retrospectively evaluated. Between January 15 and February 25, 2020, data for all cardiopulmonary resuscitation (CPR) attempts for IHCA that occurred in a tertiary teaching hospital in Wuhan, China were collected according to the Utstein style. The primary outcome was restoration of spontaneous circulation (ROSC), and the secondary outcomes were 30-day survival, and neurological outcome. RESULTS: Data from 136 patients showed 119 (87.5%) patients had a respiratory cause for their cardiac arrest, and 113 (83.1%) were resuscitated in a general ward. The initial rhythm was asystole in 89.7%, pulseless electrical activity (PEA) in 4.4%, and shockable in 5.9%. Most patients with IHCA were monitored (93.4%) and in most resuscitation (89%) was initiated <1 min. The average length of hospital stay was 7 days and the time from illness onset to hospital admission was 10 days. The most frequent comorbidity was hypertension (30.2%), and the most frequent symptom was shortness of breath (75%). Of the patients receiving CPR, ROSC was achieved in 18 (13.2%) patients, 4 (2.9%) patients survived for at least 30 days, and one patient achieved a favourable neurological outcome at 30 days. Cardiac arrest location and initial rhythm were associated with better outcomes. CONCLUSION: Survival of patients with severe COVID-19 pneumonia who had an in-hospital cardiac arrest was poor in Wuhan.


Subject(s)
Betacoronavirus , Cardiopulmonary Resuscitation/methods , Coronavirus Infections/complications , Heart Arrest/mortality , Hospital Mortality , Pneumonia, Viral/therapy , Adult , Aged , Aged, 80 and over , COVID-19 , China , Cohort Studies , Female , Heart Arrest/etiology , Heart Arrest/therapy , Humans , Male , Middle Aged , Pandemics , Pneumonia, Viral/complications , Pneumonia, Viral/etiology , Pneumonia, Viral/mortality , Prognosis , Retrospective Studies , Risk Assessment , SARS-CoV-2 , Survival Analysis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL